1887

Journal of General Virology header logo

Volume 96, Issue 9

growth, pathogenicity and serological characteristics of the Japanese encephalitis virus genotype V Muar strain Free

Abstract

The characteristics of genotype V Japanese encephalitis virus (GV JEV) remain poorly understood as only two strains have been isolated to date. In this study, we examined the effects of the GV JEV Muar strain on growth and pathogenicity in mice; we also evaluated the efficacy of inactivated JEV vaccines against the Muar strain. Although growth of the Muar strain in mouse neuroblastoma N18 cells was clearly worse than that of the GIII Beijing-1 and GI Mie/41/2002 strains, neuroinvasiveness of the Muar strain was similar to that of the Beijing-1 strain and significantly higher than that of the Mie/41/2002 strain. The results of a plaque reduction neutralization test suggested that the neutralization ability of the JEV vaccines against the Muar strain was reduced compared with the GI and GIII strains. However, the protection potency of the JEV vaccine against the Muar strain was similar to that for the Beijing-1 strain in mice. Our data indicate that GV JEV has unique growth, virulence and antigenicity features.

  • Received:
  • Accepted:
  • Published Online:
© 2015 The Authors
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.000213
2015-09-01
2024-04-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/96/9/2661.html?itemId=/content/journal/jgv/10.1099/vir.0.000213&mimeType=html&fmt=ahah

References

  1. Arai S., Matsunaga Y., Takasaki T., Tanaka-Taya K., Taniguchi K., Okabe N., Kurane I., Vaccine Preventable Diseases Surveillance Program of Japan. 2008; Japanese encephalitis: surveillance and elimination effort in Japan from 1982 to 2004. Jpn J Infect Dis 61:333–338[PubMed]
     [Google Scholar]
  2. Campbell G.L., Hills S.L., Fischer M., Jacobson J.A., Hoke C.H., Hombach J.M., Marfin A.A., Solomon T., Tsai T.F., other authors. 2011; Estimated global incidence of Japanese encephalitis: a systematic review. Bull World Health Organ 766–774:774A–774E [View Article][PubMed]
     [Google Scholar]
  3. Chen Y.Y., Fan Y.C., Tu W.C., Chang R.Y., Shih C.C., Lu I.H., Chien M.S., Lee W.C., Chen T.H., other authors. 2011; Japanese encephalitis virus genotype replacement, Taiwan, 2009–2010. Emerg Infect Dis 17:2354–2356 [View Article][PubMed]
     [Google Scholar]
  4. Crill W.D., Chang G.J. 2004; Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes. J Virol 78:13975–13986 [View Article][PubMed]
     [Google Scholar]
  5. de Wispelaere M., Frenkiel M.P., Desprès P. 2015; A Japanese encephalitis virus genotype 5 molecular clone is highly neuropathogenic in a mouse model: impact of the structural protein region on virulence. J Virol 89:5862–5875 [View Article][PubMed]
     [Google Scholar]
  6. Erlanger T.E., Weiss S., Keiser J., Utzinger J., Wiedenmayer K. 2009; Past, present, and future of Japanese encephalitis. Emerg Infect Dis 15:1–7 [View Article][PubMed]
     [Google Scholar]
  7. Erra E.O., Askling H.H., Yoksan S., Rombo L., Riutta J., Vene S., Lindquist L., Vapalahti O., Kantele A. 2013a; Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study. Vaccine 32:119–123 [View Article][PubMed]
     [Google Scholar]
  8. Erra E.O., Askling H.H., Yoksan S., Rombo L., Riutta J., Vene S., Lindquist L., Vapalahti O., Kantele A. 2013b; Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes. Clin Infect Dis 56:267–270 [View Article][PubMed]
     [Google Scholar]
  9. Fan Y.C., Chen J.M., Chiu H.C., Chen Y.Y., Lin J.W., Shih C.C., Chen C.M., Chang C.C., Chang G.J., Chiou S.S. 2012; Partially neutralizing potency against emerging genotype I virus among children received formalin-inactivated Japanese encephalitis virus vaccine. PLoS Negl Trop Dis 6:e1834 [View Article][PubMed]
     [Google Scholar]
  10. Fan Y.C., Chen J.M., Chen Y.Y., Lin J.W., Chiou S.S. 2013; Reduced neutralizing antibody titer against genotype I virus in swine immunized with a live-attenuated genotype III Japanese encephalitis virus vaccine. Vet Microbiol 163:248–256 [View Article][PubMed]
     [Google Scholar]
  11. Fulmali P.V., Sapkal G.N., Athawale S., Gore M.M., Mishra A.C., Bondre V.P. 2011; Introduction of Japanese encephalitis virus genotype I, India. Emerg Infect Dis 17:319–321 [View Article][PubMed]
     [Google Scholar]
  12. Gao X., Liu H., Wang H., Fu S., Guo Z., Liang G. 2013; Southernmost Asia is the source of Japanese encephalitis virus (genotype 1) diversity from which the viruses disperse and evolve throughout Asia. PLoS Negl Trop Dis 7:e2459 [View Article][PubMed]
     [Google Scholar]
  13. Goncalvez A.P., Chien C.H., Tubthong K., Gorshkova I., Roll C., Donau O., Schuck P., Yoksan S., Wang S.D., other authors. 2008; Humanized monoclonal antibodies derived from chimpanzee Fabs protect against Japanese encephalitis virus in vitro and in vivo. J Virol 82:7009–7021 [View Article][PubMed]
     [Google Scholar]
  14. Hasegawa H., Yoshida M., Fujita S., Kobayashi Y. 1994; Comparison of structural proteins among antigenically different Japanese encephalitis virus strains. Vaccine 12:841–844 [View Article][PubMed]
     [Google Scholar]
  15. Ishikawa T., Abe M., Masuda M. 2015; Construction of an infectious molecular clone of Japanese encephalitis virus genotype V and its derivative subgenomic replicon capable of expressing a foreign gene. Virus Res 195:153–161 [View Article][PubMed]
     [Google Scholar]
  16. Kim H., Cha G.W., Jeong Y.E., Lee W.G., Chang K.S., Roh J.Y., Yang S.C., Park M.Y., Park C., Shin E.H. 2015; Detection of Japanese encephalitis virus genotype V in Culex orientalis Culex pipiens (Diptera: Culicidae) in Korea. PLoS One 10:e0116547 [View Article][PubMed]
     [Google Scholar]
  17. Kitano T., Oya A. 1996; Japanese encephalitis vaccine. In Vaccine Handbook pp. 103–113 Edited by Researcher's Associates (Gaku-yuu-kai) of The National Institute of Health. Tokyo: Maruzen;
     [Google Scholar]
  18. Kobayashi Y., Hasegawa H., Yamauchi T. 1985; Studies on the antigenic structure of Japanese encephalitis virus using monoclonal antibodies. Microbiol Immunol 29:1069–1082 [View Article][PubMed]
     [Google Scholar]
  19. Kurane I., Takasaki T. 2000; Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains. Vaccine 18:(Suppl. 2)33–35 [View Article][PubMed]
     [Google Scholar]
  20. Li M.H., Fu S.H., Chen W.X., Wang H.Y., Guo Y.H., Liu Q.Y., Li Y.X., Luo H.M., Da W., other authors. 2011; Genotype v Japanese encephalitis virus is emerging. PLoS Negl Trop Dis 5:e1231 [View Article][PubMed]
     [Google Scholar]
  21. Liu X., Yu Y., Li M., Liang G., Wang H., Jia L., Dong G. 2011; Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China. Vaccine 29:2127–2130 [View Article][PubMed]
     [Google Scholar]
  22. Ma S.P., Yoshida Y., Makino Y., Tadano M., Ono T., Ogawa M. 2003; Short report: a major genotype of Japanese encephalitis virus currently circulating in Japan. Am J Trop Med Hyg 69:151–154[PubMed]
     [Google Scholar]
  23. Monath T.P., Arroyo J., Levenbook I., Zhang Z.X., Catalan J., Draper K., Guirakhoo F. 2002; Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines. J Virol 76:1932–1943 [View Article][PubMed]
     [Google Scholar]
  24. Morita K., Tadano M., Nakaji S., Kosai K., Mathenge E.G., Pandey B.D., Hasebe F., Inoue S., Igarashi A. 2001; Locus of a virus neutralization epitope on the Japanese encephalitis virus envelope protein determined by use of long PCR-based region-specific random mutagenesis. Virology 287:417–426 [View Article][PubMed]
     [Google Scholar]
  25. Nam J.H., Chung Y.J., Ban S.J., Kim E.J., Park Y.K., Cho H.W. 1996; Envelope gene sequence variation among Japanese encephalitis viruses isolated in Korea. Acta Virol 40:303–309[PubMed]
     [Google Scholar]
  26. Nga P.T., del Carmen Parquet M., Cuong V.D., Ma S.P., Hasebe F., Inoue S., Makino Y., Takagi M., Nam V.S., Morita K. 2004; Shift in Japanese encephalitis virus (JEV) genotype circulating in northern Vietnam: implications for frequent introductions of JEV from Southeast Asia to East Asia. J Gen Virol 85:1625–1631 [View Article][PubMed]
     [Google Scholar]
  27. Nitatpattana N., Dubot-Pérès A., Gouilh M.A., Souris M., Barbazan P., Yoksan S., de Lamballerie X., Gonzalez J.P. 2008; Change in Japanese encephalitis virus distribution, Thailand. Emerg Infect Dis 14:1762–1765 [View Article][PubMed]
     [Google Scholar]
  28. Pan X.L., Liu H., Wang H.Y., Fu S.H., Liu H.Z., Zhang H.L., Li M.H., Gao X.Y., Wang J.L., other authors. 2011; Emergence of genotype I of Japanese encephalitis virus as the dominant genotype in Asia. J Virol 85:9847–9853 [View Article][PubMed]
     [Google Scholar]
  29. Pierson T.C., Diamond M.S. 2013; Flaviviruses. In Fields Virology, 6th edn. pp. 747–794 Edited by Knipe D. M., Howley P. M. Philadelphia: Lippincott Williams & Wilkins;
     [Google Scholar]
  30. Schuh A.J., Ward M.J., Leigh Brown A.J., Barrett A.D. 2014; Dynamics of the emergence and establishment of a newly dominant genotype of Japanese encephalitis virus throughout Asia. J Virol 88:4522–4532 [View Article][PubMed]
     [Google Scholar]
  31. Seo H.J., Kim H.C., Klein T.A., Ramey A.M., Lee J.H., Kyung S.G., Park J.Y., Cho Y.S., Cho I.S., Yeh J.Y. 2013; Molecular detection and genotyping of Japanese encephalitis virus in mosquitoes during a 2010 outbreak in the Republic of Korea. PLoS One 8:e55165 [View Article][PubMed]
     [Google Scholar]
  32. Solomon T., Ni H., Beasley D.W., Ekkelenkamp M., Cardosa M.J., Barrett A.D. 2003; Origin and evolution of Japanese encephalitis virus in Southeast Asia. J Virol 77:3091–3098 [View Article][PubMed]
     [Google Scholar]
  33. Sumiyoshi H., Tignor G.H., Shope R.E. 1995; Characterization of a highly attenuated Japanese encephalitis virus generated from molecularly cloned cDNA. J Infect Dis 171:1144–1151 [View Article][PubMed]
     [Google Scholar]
  34. Tajima S., Nerome R., Nukui Y., Kato F., Takasaki T., Kurane I. 2010; A single mutation in the Japanese encephalitis virus E protein (S123R) increases its growth rate in mouse neuroblastoma cells and its pathogenicity in mice. Virology 396:298–304 [View Article][PubMed]
     [Google Scholar]
  35. Takhampunya R., Kim H.C., Tippayachai B., Kengluecha A., Klein T.A., Lee W.J., Grieco J., Evans B.P. 2011; Emergence of Japanese encephalitis virus genotype V in the Republic of Korea. Virol J 8:449 [View Article][PubMed]
     [Google Scholar]
  36. Tsai T.F. 2000; New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13–15 October 1998. Vaccine 18:(Suppl. 2)1–25 [View Article][PubMed]
     [Google Scholar]
  37. Vogt M.R., Moesker B., Goudsmit J., Jongeneelen M., Austin S.K., Oliphant T., Nelson S., Pierson T.C., Wilschut J., other authors. 2009; Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step. J Virol 83:6494–6507 [View Article][PubMed]
     [Google Scholar]
  38. Wang H.Y., Takasaki T., Fu S.H., Sun X.H., Zhang H.L., Wang Z.X., Hao Z.Y., Zhang J.K., Tang Q., other authors. 2007; Molecular epidemiological analysis of Japanese encephalitis virus in China. J Gen Virol 88:885–894 [View Article][PubMed]
     [Google Scholar]
  39. Wu K.P., Wu C.W., Tsao Y.P., Kuo T.W., Lou Y.C., Lin C.W., Wu S.C., Cheng J.W. 2003; Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein. J Biol Chem 278:46007–46013 [View Article][PubMed]
     [Google Scholar]
  40. Yamaguchi Y., Nukui Y., Tajima S., Nerome R., Kato F., Watanabe H., Takasaki T., Kurane I. 2011; An amino acid substitution (V3I) in the Japanese encephalitis virus NS4A protein increases its virulence in mice, but not its growth rate in vitro . J Gen Virol 92:1601–1606 [View Article][PubMed]
     [Google Scholar]
  41. Yang D.K., Kim B.H., Kweon C.H., Kwon J.H., Lim S.I., Han H.R. 2004; Molecular characterization of full-length genome of Japanese encephalitis virus (KV1899) isolated from pigs in Korea. J Vet Sci 5:197–205[PubMed]
     [Google Scholar]
  42. Yoshida Y., Tabei Y., Hasegawa M., Nagashima M., Morozumi S. 2005; Genotypic analysis of Japanese encephalitis virus strains isolated from swine in Tokyo, Japan. Jpn J Infect Dis 58:259–261[PubMed]
     [Google Scholar]
  43. Yun S.M., Cho J.E., Ju Y.R., Kim S.Y., Ryou J., Han M.G., Choi W.Y., Jeong Y.E. 2010; Molecular epidemiology of Japanese encephalitis virus circulating in South Korea, 1983–2005. Virol J 7:127 [View Article][PubMed]
     [Google Scholar]
  44. Zhang J.S., Zhao Q.M., Zhang P.H., Jia N., Cao W.C. 2009; Genomic sequence of a Japanese encephalitis virus isolate from southern China. Arch Virol 154:1177–1180 [View Article][PubMed]
     [Google Scholar]
  45. Zhang J.S., Zhao Q.M., Guo X.F., Zuo S.Q., Cheng J.X., Jia N., Wu C., Dai P.F., Zhao J.Y. 2011; Isolation and genetic characteristics of human genotype 1 Japanese encephalitis virus, China, 2009. PLoS One 6:e16418 [View Article][PubMed]
     [Google Scholar]
  46. Zhao Z., Date T., Li Y., Kato T., Miyamoto M., Yasui K., Wakita T. 2005; Characterization of the E-138 (Glu/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone. J Gen Virol 86:2209–2220 [View Article][PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.000213
Loading
In vitro growth, pathogenicity and serological characteristics of the Japanese encephalitis virus genotype V Muar strain
J. Gen. Virol. 96, 2661 (2015); https://doi.org/10.1099/vir.0.000213
/content/journal/jgv/10.1099/vir.0.000213
/content/journal/jgv/10.1099/vir.0.000213
Loading

Data & Media loading...

Supplements

Supplementary Data

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error